Brian Feth

Brian Feth is co-founder and CEO of Xcell Biosciences Inc., a San Francisco-based life science company. Brian has led the company through the product development and launch of several platforms in the cell therapy space and has raised over $50M in financing since inception from a number of notable investors including Casdin Capital, Viking Global, HBM Healthcare, Lightspeed, Dynamk Capital, Illumina, and Labcorp, among others. Prior to Xcellbio, Brian worked with Strategyn Equity Partners, a mid-market private equity firm and with L.E.K. Consulting, a business strategy management consulting firm where he focused on advising life science diagnostic and research tools clients in corporate strategy, product strategy and planning, and transaction support. Brian has also lived and worked in several countries in Africa with the non-profit, TechnoServe, where he wrote a grant for and led the launch of a $13M program funded by the Gates Foundation and Coca-Cola to double the incomes of 54,000 farmers. Brian earned his Masters of Business Administration from UC Berkeley’s Haas School of Business, his Masters in Bioscience from the Keck Graduate Institute of Applied Sciences, and Bachelor of Science degrees with honors in both Molecular Biology and in Chemistry from Purdue University.